Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
批准号:
7268102
负责人:
MARC C. LEVESQUE
金额:
$22.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2009-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In humans, autoimmune disorders such as rheumatoid arthritis (RA) are characterized by increased inflammatory cytokine production including overproduction of TNFa. Many rheumatic disorders are also characterized by alterations in B cell subsets and autoantibody production. In RA, the administration of agents that neutralize TNFa promotes resolution of clinical symptoms and reductions in rheumatoid factor production. The success of anti-B cell therapies in RA underscores the importance of B cells to the pathogenesis of RA and highlights possible interconnections between the overproduction of TNFa and B cell abnormalities in rheumatic inflammatory diseases. In mice, the administration of inflammatory stimuli such as adjuvants or TNFa, induces the emigration of immature B cells from the bone marrow to the peripheral blood and spleen. These B cell emigrants have the characteristics of immature B cells and contain subpopulations that expand in colony forming assays, and subpopulations that express AID and have somatically mutated immunoglobulin genes despite their development outside germinal centers. Importantly, the administration of adjuvants such as Freund's or pristane to susceptible rodent strains is associated with the development of arthritis and lupus-like symptoms and the development of autoantibodies. B cells with immature phenotypes accumulate in the synovial tissue of RA patients. Therefore, although speculative, we believe that there may be an important relationship between TNFa-induced pre-B cell bone marrow emigrants and the subsequent development of autoimmunity. We also believe that this population of peripheral pre-B cells may represent the precursors for populations of B cells identified in X-linked hyper IgM syndrome patients that contain somatically mutated immunoglobulin genes despite the absence of germinal centers in these patients. Patients with hyper IgM syndrome develop autoantibodies and autoimmune syndromes. Studies on TNFa-induced pre-B cell bone marrow emigrants have not been performed in humans. Therefore, we will determine whether similar populations of pre-B cells can be detected in human peripheral blood and we will characterize these B cells phenotypically and functionally. We believe that B cell populations similar to TNFa-induced pre-B cell bone marrow emigrants in mice will be expanded in human cord blood samples, in peripheral blood in human subjects administered adjuvant, and in patients with RA. We will also determine whether anti-TNFa therapy is associated with reductions in peripheral populations of TNFa- induced pre-B cell bone marrow emigrants in RA patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
-
批准号:8522158
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2010
-
负责人:MARC C. LEVESQUE
-
依托单位:
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
-
批准号:8318804
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2010
-
负责人:MARC C. LEVESQUE
-
依托单位:
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
-
批准号:8146973
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2010
-
负责人:MARC C. LEVESQUE
-
依托单位:
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
-
批准号:8088402
-
项目类别:
-
资助金额:$32.11万
-
财政年份:2010
-
负责人:MARC C. LEVESQUE
-
依托单位:
Randomized observation study of biologic therapy for rheumatoid arthritis
-
批准号:8040371
-
项目类别:
-
资助金额:$16.47万
-
财政年份:2010
-
负责人:MARC C. LEVESQUE
-
依托单位:
Randomized observation study of biologic therapy for rheumatoid arthritis
-
批准号:7942942
-
项目类别:
-
资助金额:$136.69万
-
财政年份:2009
-
负责人:MARC C. LEVESQUE
-
依托单位:
Randomized observation study of biologic therapy for rheumatoid arthritis
-
批准号:7856255
-
项目类别:
-
资助金额:$134.06万
-
财政年份:2009
-
负责人:MARC C. LEVESQUE
-
依托单位:
Prevention of Chronic Lymphocytic Leukemia (CLL)
-
批准号:7490723
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2007
-
负责人:MARC C. LEVESQUE
-
依托单位:
Prevention of Chronic Lymphocytic Leukemia (CLL)
-
批准号:7263427
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2007
-
负责人:MARC C. LEVESQUE
-
依托单位:
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
-
批准号:7105129
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2006
-
负责人:MARC C. LEVESQUE
-
依托单位:
NITRIC OXIDE, LPS AND THE PATHOGENESIS OF ASTHMA
-
批准号:7198488
-
项目类别:
-
资助金额:$1.88万
-
财政年份:2005
-
负责人:MARC C. LEVESQUE
-
依托单位:
Nitric Oxide, LPS and the Pathogenesis of Asthma
-
批准号:6974056
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2004
-
负责人:MARC C. LEVESQUE
-
依托单位:
Nitric Oxide Metabolism in Statin-treated Pediatric SLE
-
批准号:6775054
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2003
-
负责人:MARC C. LEVESQUE
-
依托单位:
Nitric Oxide Metabolism in Statin-treated Pediatric SLE
-
批准号:6804001
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2003
-
负责人:MARC C. LEVESQUE
-
依托单位:
Nitric Oxide Metabolism in Statin-treated Pediatric SLE
-
批准号:6915214
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2003
-
负责人:MARC C. LEVESQUE
-
依托单位:
Nitric Oxide Metabolism in Statin-treated Pediatric SLE
-
批准号:7093480
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2003
-
负责人:MARC C. LEVESQUE
-
依托单位:
HYALURONAN MEDIATED NITRIC OXIDE PRODUCTION BY MACROPHAG
-
批准号:6022207
-
项目类别:
-
资助金额:$7.05万
-
财政年份:1999
-
负责人:MARC C. LEVESQUE
-
依托单位:
HYALURONAN-MEDIATED NITRIC OXIDE PRODUCTION BY MACROPHAG
-
批准号:6171624
-
项目类别:
-
资助金额:$7.05万
-
财政年份:1999
-
负责人:MARC C. LEVESQUE
-
依托单位:
HYALURONAN-MEDIATED NITRIC OXIDE PRODUCTION BY MACROPHAG
-
批准号:6375278
-
项目类别:
-
资助金额:$7.05万
-
财政年份:1999
-
负责人:MARC C. LEVESQUE
-
依托单位:
IMMUNOREGULATORY FUNCTIONS OF THE ISOFORMS OF CD44
-
批准号:2077474
-
项目类别:
-
资助金额:$5.22万
-
财政年份:1993
-
负责人:MARC C. LEVESQUE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TNFa 下调PLGF 促早发型子痫前期免疫损伤机制研究
-
批准号:2021JJ30693
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:吴仕元
-
依托单位:
基于肿瘤EMT炎症微环境的Anti-TNFa-VHH-RGD4C融合纳米抗体设计及作用机制研究
-
批准号:81603017
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2016
-
负责人:纪雪梅
-
依托单位:
利用肿瘤穿透肽瘤内靶向递送TNFa增强抗肿瘤作用及机制研究
-
批准号:81573336
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2015
-
负责人:卢晓风
-
依托单位:
TNFa信号通路在多能干细胞造血分化中的调控作用及其机制研究
-
批准号:81570098
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2015
-
负责人:郑伟燕
-
依托单位:
TNFa及其下游分子miR-155在盐敏感性高血压及其相关血管内皮细胞功能障碍中的作用研究
-
批准号:81470532
-
项目类别:面上项目
-
资助金额:72.0万元
-
批准年份:2014
-
负责人:周明生
-
依托单位:
Nur77在介导HBx和TNFa协同促进肝癌中的新型作用机制
-
批准号:31471273
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2014
-
负责人:曾锦章
-
依托单位:
夹氧杂蒽酮类化合物调控tRXRa介导的TNFa生死转换的作用机制研究
-
批准号:81370097
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:王光辉
-
依托单位:
TNFa下调类风关Treg细胞磷酸化Foxp3表达及促进Th17细胞分化机制研究
-
批准号:81072470
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2010
-
负责人:聂红
-
依托单位:
靶向融合蛋白GnRH-TNFa克服肿瘤细胞TNFa抗性的机制
-
批准号:30772585
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2007
-
负责人:李涛
-
依托单位:
IL-10对急性坏死性胰腺炎时肝损害Bcl-2、Bax、P38、TNFa表达影响
-
批准号:30271264
-
项目类别:面上项目
-
资助金额:7.0万元
-
批准年份:2002
-
负责人:谷俊朝
-
依托单位: